CURATOLO, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 64.538
AS - Asia 5.136
EU - Europa 4.758
SA - Sud America 1.020
AF - Africa 71
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 9
Totale 75.568
Nazione #
US - Stati Uniti d'America 64.397
SG - Singapore 2.642
UA - Ucraina 853
BR - Brasile 846
CN - Cina 827
DE - Germania 811
IE - Irlanda 653
HK - Hong Kong 627
IT - Italia 604
RU - Federazione Russa 394
FR - Francia 319
GB - Regno Unito 310
KR - Corea 287
VN - Vietnam 250
FI - Finlandia 210
PL - Polonia 180
SE - Svezia 118
NL - Olanda 109
IN - India 94
JP - Giappone 82
CA - Canada 78
AR - Argentina 71
ID - Indonesia 50
BD - Bangladesh 45
MX - Messico 44
TR - Turchia 39
AT - Austria 36
TW - Taiwan 35
IQ - Iraq 34
AU - Australia 33
ES - Italia 32
BE - Belgio 28
EC - Ecuador 28
CZ - Repubblica Ceca 26
ZA - Sudafrica 23
VE - Venezuela 21
CO - Colombia 18
MY - Malesia 14
PK - Pakistan 14
RO - Romania 14
UZ - Uzbekistan 14
MA - Marocco 13
CL - Cile 12
KE - Kenya 11
IR - Iran 10
LT - Lituania 10
GR - Grecia 9
PE - Perù 9
AL - Albania 8
NP - Nepal 8
PH - Filippine 8
IL - Israele 7
KG - Kirghizistan 7
KZ - Kazakistan 7
UY - Uruguay 7
CH - Svizzera 6
DZ - Algeria 6
EU - Europa 6
PT - Portogallo 6
PY - Paraguay 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
JO - Giordania 5
TN - Tunisia 5
BG - Bulgaria 4
DO - Repubblica Dominicana 4
LB - Libano 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
ET - Etiopia 3
NO - Norvegia 3
OM - Oman 3
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DK - Danimarca 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
KW - Kuwait 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
SM - San Marino 2
TT - Trinidad e Tobago 2
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
GD - Grenada 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
KN - Saint Kitts e Nevis 1
LV - Lettonia 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
Totale 75.559
Città #
Woodbridge 19.129
Wilmington 17.323
Houston 14.326
Fairfield 2.351
Ann Arbor 1.522
Singapore 1.356
Ashburn 1.067
Seattle 899
Chandler 842
Cambridge 829
Jacksonville 737
Dublin 615
Hong Kong 610
Medford 489
Dearborn 438
Beijing 424
Santa Clara 313
Lawrence 230
New York 213
Los Angeles 191
Rome 172
Kraków 155
The Dalles 139
Buffalo 129
Dallas 111
San Diego 110
Norwalk 96
Menlo Park 94
Moscow 90
Mülheim 87
Ho Chi Minh City 84
Chicago 83
Munich 71
São Paulo 63
Council Bluffs 58
London 56
Milan 56
Hanoi 51
Redwood City 47
Nuremberg 46
Redondo Beach 40
University Park 38
Zhengzhou 37
Jakarta 33
Taipei 33
Verona 33
Boardman 30
Tokyo 29
Salt Lake City 28
Falls Church 27
Rio de Janeiro 27
Saint Petersburg 26
Belo Horizonte 25
Brno 25
Mountain View 25
Toronto 25
Chennai 24
Hyderabad 24
Nanjing 24
Seoul 23
Warsaw 22
Phoenix 21
Brussels 20
Guangzhou 20
Kunming 20
San Mateo 20
Brasília 19
Montreal 19
Nijmegen 19
Shanghai 19
Denver 18
Lappeenranta 17
San Francisco 17
Hefei 16
Helsinki 16
Stockholm 16
Vienna 16
Brooklyn 15
Detroit 15
Columbus 14
Curitiba 14
Poplar 14
Dhaka 13
Elk Grove Village 13
Nürnberg 13
Porto Alegre 13
Sydney 13
Melbourne 12
Mexico City 12
Redmond 12
Da Nang 11
Del Norte 11
Frankfurt am Main 11
Johannesburg 11
Amsterdam 10
Bari 10
Boston 10
Charlotte 10
Lancaster 10
Mumbai 10
Totale 66.870
Nome #
Current role of perampanel in pediatric epilepsy 504
Zonisamide in children and young adults with refractory epilepsy: an open label, multicenter Italian study 483
Human endogenous retroviruses and ADHD 469
Are caesarean sections, induced labor and oxytocin regulation linked to Autism Spectrum Disorders 464
Oxygen exchange and energy metabolism in erythrocytes of Rett syndrome and their relationships with respiratory alterations 463
Tourette Syndrome and comorbid ADHD: Current pharmacological treatment options. 462
Neurological and neuropsychiatric aspects of tuberous sclerosis complex. 460
Association between presenilin-1 -48C/T polymorphism and Down's syndrome 459
ADHD and epilepsy in children with Tourette syndrome: a triple comorbidity? 451
The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions 450
Association study of autistic disorder and chromosome 16p 449
Tourette syndrome and comorbid ADHD: causes and consequences 444
Adhd and human endogenous retroviruses 442
Comorbidity of ADHD and dyslexia. 440
mTOR Inhibitors in Tuberous Sclerosis Complex. 439
Two epileptic syndromes, one brain: Childhood absence epilepsy and benign childhood epilepsy with centrotemporal spikes 438
Reduction in Retinal Nerve Fiber Layer Thickness in Young Adults with Autism Spectrum Disorders 436
Impairment in flexible regulation of speed and accuracy in children with ADHD 435
The association of rs4307059 and rs35678 markers with autism spectrum disorders is replicated in Italian families 435
Website and Headache: Assessment of The Information Quality using the DISCERN Tool 432
Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study. 432
Interstitial deletion of a proximal 3p: a clinically recognisable syndrome 431
Association of adenosine deaminase polymorphism with mild mental retardation 431
Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1. 431
Convulsive disorder and the genetics of signal transduction; a study of a low molecular weight protein tyrosine phosphatase in a pediatric sample 427
Convulsive disorder and genetic polymorphism. Association of idiopathic generalized epilepsy with haptoglobin polymorphism 420
Long term clinical course of Tourette syndrome. 420
MTHFR C677T and A1298C polymorphisms and cerebral stroke in two twin gestations 420
Genotype/Phenotype Correlations in Tuberous Sclerosis Complex. 420
Neurological soft signs are associated with attentional dysfunction in children with attention deficit hyperactivity disorder 419
Efficacy of intensive versus nonintensive physiotherapy in children with cerebral palsy: a meta-analysis. 417
Cortical maldevelopment in congenital cytomegalovirus infection transmitted by a woman with preexisting immunity. 417
Rufinamide for the treatment of refractory epilepsy secondary to neuronal migration disorders. 417
Current role of melatonin in pediatric neurology: Clinical recommendations 417
Reduction in retinal nerve fiber layer thickness in tuberous sclerosis complex. 413
Principal pathogenetic components and biological endophenotypes in autism spectrum disorders. 412
Management of epilepsy in tuberous sclerosis complex 412
Medical treatment in children with central nervous system malformations 412
Mammalian Target of Rapamycin Inhibitors and Life-Threatening Conditions in Tuberous Sclerosis Complex. 412
Conceptual and methodological challenges for neuroimaging studies of autistic spectrum disorders. 412
Lack of association between IDE genetic variability and Down's syndrome 411
Use of the DISCERN tool for evaluating web searches in childhood epilepsy. 410
Can biological components predict short-term evolution in Autism Spectrum Disorders? A proof-of-concept study 409
Candidate gene study of HOXB1 in autism spectrum disorder. 408
Optical coherence tomography and infrared images of astrocytic hamartomas not revealed by funduscopy in tuberous sclerosis complex 408
Cluster analysis of autistic patients based on principal pathogenetic components. 407
Urinary p-cresol is elevated in small children with severe autism spectrum disorder. 405
Is mTOR inhibition a systemic treatment for tuberous sclerosis? 404
Synapses as therapeutic targets for autism spectrum disorders: an international symposium held in pavia on july 4th, 2014. 404
Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations. 403
Timing and clinical characteristics of topiramate-induced psychosis in a patient with epilepsy and tuberous sclerosis 403
Methylphenidate-induced visual hallucinations. 402
De novo mosaic ring chromosome 18 in a child with mental retardation, epilepsy and immunological problems 402
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial. 402
Early onset epileptic encephalopathy or genetically determined encephalopathy with early onset epilepsy? Lessons learned from TSC 402
Epilepsy in tuberous sclerosis complex. 401
Hypnic headache in children. 400
Planning deficit in children with neurofibromatosis type 1: a neurocognitive trait independent from attention-deficit hyperactivity disorder (ADHD)? 400
TuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline data on 2093 patients. 400
Child neurology: role of the International Association. 399
Long-term neurological outcome of a sextuplet pregnancy. 398
Cognitive and behavioral effects of new antiepileptic drugs in pediatric epilepsy 397
Attention and executive functions profile in drug naive ADHD subtypes 396
Two-loci ADA haplotypes in autistic disorder 396
Refractory absence seizures: An Italian multicenter retrospective study 396
Neurocognitive effects of methylphenidate on ADHD children with different DAT genotypes: a longitudinal open label trial 395
Effectiveness of community-based treatment on clinical outcome in children with autism spectrum disorders: An Italian prospective study. 395
Lack of association between MTHFR C677T and MTHFR A1298C genetic polymorphisms and mental retardation 394
Tourette syndrome and comorbid conditions: a spectrum of different severities and complexities 394
Epilepsy associated with autism and attention deficit hyperactivity disorder: is there a genetic link? 394
Early-onset pure absence epilepsy: a distinct epileptic syndrome. 393
Detection of auto-antibodies to DAT in the serum: interactions with DAT genotype and psycho-stimulant therapy for ADHD. 393
Benign childhood epilepsy with centrotemporal spikes and the multicomponent model of attention: a matched control study. 391
Recommendations for early diagnosis and intervention in autism spectrum disorders: an Italian-Israeli consensus conference 390
Abnormal parieto-motor connectivity in Tuberous Sclerosis Complex 389
Attention and executive functions profile in childhood absence epilepsy. 389
Clinical Reasoning: A girl presenting with stiffness episodes during sleep, café-au-lait spots, and flecked retina 389
Massive hepatic angiomyolipoma in a young woman with tuberous sclerosis complex: Significant clinical improvement during tamoxifen treatment 388
Autism in tuberous sclerosis 388
Late-onset epileptic spasms in children with Pallister-Killian syndrome: a report of two new cases and review of the electroclinical aspects. 388
Preterm birth and neurodevelopmental outcome: a review 388
Rufinamide in refractory childhood epileptic encephalopathies other than Lennox-Gastaut syndrome 387
Autism: evidence of association with adenosine deaminase genetic polymorphism 386
Neurobehavioral phenotype observed in KBG syndrome caused by ANKRD11 mutations 385
HERVs expression in autism spectrum disorders 384
Syndromic autism: Causes and pathogenetic pathways 383
Association of Trp53 polymorphic variants at codon 72 with nonsyndromic mental retardation 383
Headache and attention deficit and hyperactivity disorder in children: common condition with complex relation and disabling consequences 383
Metastatic Group 3 Medulloblastoma in a Patient With Tuberous Sclerosis Complex: Case Description and Molecular Characterization of the Tumor 383
Genetic polymorphism and idiopathic generalized epilepsy. Evidence of interaction between haptoglobin and ACP1 systems 382
The neurobiology of attention deficit/hyperactivity disorder. 382
Introduction. 382
Sleep abnormalities in mentally retarded autistic subjects: Down's syndrome with mental retardation and normal subjects 381
The relationship between sleep and epilepsy: the effect on cognitive functioning in children. 380
MRI appearance of Sturge-Weber syndrome in tuberous sclerosis complex: is the neural crest the culprit? 379
Altered anandamide degradation in attention-deficit/hyperactivity disorder 377
Current role of rufinamide in the treatment of childhood epilepsy: literature review and treatment guidelines 377
Pancreatic neuroendocrine tumor in a child with a tuberous sclerosis complex 2 (TSC2) mutation 377
Attention-deficit hyperactivity disorder (ADHD) and tuberous sclerosis complex 377
Rufinamide for refractory focal seizures: an open-label, multicenter European study. 376
Totale 41.012
Categoria #
all - tutte 169.626
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 169.626


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.551 0 0 0 0 0 1.149 1.286 1.000 267 277 451 121
2021/20222.031 95 203 83 44 40 203 111 80 207 182 178 605
2022/20232.429 270 203 61 236 216 617 249 142 198 13 166 58
2023/2024762 123 21 45 10 59 193 27 19 19 22 54 170
2024/20255.329 147 1.359 687 315 108 341 416 235 412 661 300 348
2025/20263.478 588 389 969 636 790 106 0 0 0 0 0 0
Totale 76.145